Patient Capacity in Chronic Kidney Disease Trajectories

Overview

About this study

The purpose of this study is to rigorously examine whether patient capacity at baseline is predictive of multiple outcomes of interest to patients, clinicians, and other stakeholders.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Aged 18 or over.
Chronic Kidney Disease stage 4 or 5 at time of enrollment.

Exclusion Criteria:

Patients who are unable to read and write in English or with barriers to informed consent (e.g., cognitive impairment) will be excluded.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/21/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Kasey Boehmer, Ph.D., M.P.H.	Open for enrollment	Contact information: Kasey Boehmer Ph.D., M.P.H. (507) 293-0175 Boehmer.Kasey@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kasey Boehmer, Ph.D., M.P.H.

Open for enrollment

Contact information:

Kasey Boehmer Ph.D., M.P.H.

(507) 293-0175

Boehmer.Kasey@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials